Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Cryoport Inc (CYRX)

Cryoport Inc (CYRX)
5.62 x 1 6.00 x 4
Post-market by (Cboe BZX)
5.77 +0.54 (+10.33%) 04/11/25 [NASDAQ]
5.62 x 1 6.00 x 4
Post-market 5.77 unch (unch) 16:02 ET
News & Headlines for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
New Strong Buy Stocks for January 29th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Moelis & Company MC: This investment banking advisory company has seen the Zacks Consensus Estimate for its current year earnings...

CYRX : 5.77 (+10.33%)
HCP : 34.78 (-0.09%)
MC : 50.60 (-0.35%)
LFST : 6.84 (+1.03%)
EAT : 143.77 (+0.70%)
Insider Sale: Director at $CYRX (CYRX) Sells 7,369 Shares

Ramkumar Mandalam, a director at $CYRX ($CYRX), sold 7,369 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 11.0% of their shares....

CYRX : 5.77 (+10.33%)
Insider Sale: President of $CYRX (CYRX) Sells 22,817 Shares

JERRELL SHELTON, the President of $CYRX ($CYRX), sold 22,817 shares of the company on 11-22-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.0% of their...

CYRX : 5.77 (+10.33%)
Insider Sale: President of $CYRX (CYRX) Sells 50,000 Shares

JERRELL SHELTON, the President of $CYRX ($CYRX), sold 50,000 shares of the company on 11-19-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 6.6% of their...

CYRX : 5.77 (+10.33%)
Cryoport Inks New Multi-Year Supply Chain Solutions Agreement with Monash IVF

/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and services to the fast-growing...

MVF : 6.66 (+0.76%)
CYRX : 5.77 (+10.33%)
Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies

/PRNewswire/ -- Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, and...

CYRX : 5.77 (+10.33%)
Cryoport Receives 2023 IMAPAC Asia Pacific Cell & Gene Therapy Excellence Award

/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and services to the fast-growing...

CYRX : 5.77 (+10.33%)
Cryoport Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and services to the fast-growing...

CYRX : 5.77 (+10.33%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cryoport, Inc. - CYRX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cryoport, Inc. ("Cryoport" or the "Company") (NASDAQ: CYRX). Such investors are...

CYRX : 5.77 (+10.33%)
Cryoport to Report Second Quarter 2023 Financial Results on August 9, 2023

/PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and services for the fast growing...

CYRX : 5.77 (+10.33%)

Barchart Exclusives

This Nvidia-Backed AI Stock Is Shrugging Off Market Pain Thanks to the FDA. Should You Buy Shares Now?
Recursion Pharmaceuticals stock rallied as FDA announces plans of using AI for drug testing. Is it too late to invest in RXRX shares? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar